Andfjord Salmon (ANDF) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Achieved major milestones at Kvalnes, including seawater filling of the outlet tunnel and successful infrastructure testing, advancing operational readiness for land-based salmon farming.
Optimized build-out plan increased Kvalnes production capacity by 20%, raising expected output from 8,000 to 11,000 tonnes (HOG + post-smolt) for Phase 1 and total site output from 19,000 to 23,700 tonnes under the current license.
Phase 2A construction underway, adding 6,000 tonnes of production volume, with strong progress on pools and infrastructure.
First production cycle demonstrated high growth, 97.5% survival rate, 1.05 feed conversion ratio, 91.1% superior share, and low energy consumption, validating the facility's sustainable concept.
Secured NOK 1.4 billion in funding through loans, sale and leaseback, and private placement; NOK 400 million equity issue completed at NOK 36.80 per share to cover CapEx overruns.
Financial highlights
Q1 2025 revenue was NOK 57,000, down from NOK 190,000 in Q1 2024; net loss for Q1 2025 was NOK 18 million, compared to NOK 15.7 million in Q1 2024.
Cash and cash equivalents at Q1 2025 stood at NOK 178.9 million, up from NOK 59.2 million at year-end 2024.
Net cash outflow from operating activities was NOK -18.5 million in Q1 2025.
Total assets at Q1 2025 were NOK 3,129.9 million, with total equity at NOK 1,807.5 million and borrowings at NOK 830.8 million.
Outlook and guidance
Smolt release and start of operations planned for September 2025, with continuous batch introductions and production ramp-up as new pools become ready.
Full Kvalnes site expected to deliver 48,100 tonnes of production once fully scaled, with blended CapEx now estimated at NOK 115/kg.
Further financing for working capital and liquidity is being considered, including a potential bond issue.
Latest events from Andfjord Salmon
- Kvalnes expansion advances ahead of schedule, with strong liquidity and regulatory stability.ANDF
Q3 20248 Jul 2026 - Survival rates above 99% and strong growth drive expansion amid ongoing legal dispute.ANDF
Q1 202628 May 2026 - Strong growth, high survival rates, and robust expansion supported by strategic partnerships.ANDF
Company presentation23 Apr 2026 - Survival rates above 99.5% and rapid growth drive expansion toward 11,000t capacity in 2026.ANDF
Q4 202525 Feb 2026 - Kvalnes expansion accelerates, equity raised, and "post-smolt" strategy to lift EBIT.ANDF
Q2 202422 Jan 2026 - Kvalnes nears completion with 20% capacity boost, full funding, and regulatory readiness.ANDF
Investor Update26 Dec 2025 - First salmon sales, high survival rates, and major capital raise drive expansion.ANDF
Q3 202516 Dec 2025 - Raised NOK 1.55 billion, completed infrastructure, and prepares for large-scale smolt release.ANDF
Q2 202516 Dec 2025 - Strong asset and revenue growth in 2024 with industry-leading operational progress.ANDF
Q4 202428 Nov 2025